NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

Cboe BZX · Health · USD · ETF

ARK Genomic Revolution ETF (ARKG) ETF Analysis

ARKG
Expense ratio 0.75% Yield 0% Assets $2.22B Since October 31, 2014 Family ARK ETF Trust

Last Updated: October 21, 2026

$49.85
+$1.20 (+2.47%)

October 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare ARKG with… →

ARKG Annualized Returns

PeriodAnnualized$100 becomes
1 year+52.63%$152.63
3 years+28.04%$209.89
5 years−7.91%$66.23
10 years+11.78%$304.67

Returns are total returns computed from daily closes, with dividends reinvested. As of October 21, 2026.

ARKG Return by Calendar Year

2016 and 2026 are partial years

View as table ↓View as chart ↑
YearReturn
2026 (partial year)+72.07%
2025+23.04%
2024−28.24%
2023+16.22%
2022−53.90%
2021−33.92%
2020+180.40%
2019+44.00%
2018−0.12%
2017+46.61%
2016 (partial year)−11.19%

ARKG Monthly Returns

−26%+31%
YearJanFebMarAprMayJunJulAugSepOctNovDec
2026+5.0−1.5−11.9+13.1+16.0+21.4−8.3+22.5+14.8−8.1——
2025+14.0−8.3−15.7+5.9−4.9+16.4−2.2+3.8+12.3+12.1+0.2−7.1
2024−13.3+10.8−8.7−19.0+5.2−4.2+14.8−2.1−3.0−9.6+12.3−9.4
2023+19.4−9.9−0.9−3.7+9.2+7.8+11.5−15.1−13.6−17.4+20.5+18.3
2022−18.8−2.7−5.1−26.0−5.1−2.4+16.3−3.1−7.4+2.7−3.7−13.1
2021+9.3−8.3−5.1+0.2−8.0+13.1−8.8+1.6−12.8+0.5−15.6−2.8
2020−2.4+5.1−9.0+30.1+13.9+12.6+3.0+15.3+2.9+3.2+24.3+15.0
2019+17.7+9.1+6.8−0.5−11.0+18.4+0.3−9.1−6.1+1.5+16.6−1.1
2018+13.1−1.8−5.3−1.3+15.0−0.6+1.2+17.2−3.0−17.3+7.8−17.9
2017+7.5+9.1+4.2−0.9−1.6+11.0−0.4+12.8+4.3−1.1−1.1−3.4

Monthly total returns with dividends reinvested; each cell prints its signed value.

ARKG Volatility & Risk

Volatility: 10 yrs · Beta: 3 yrs
Annualized volatility
41.94%
Beta (3y)
2.21
Best year
+180.40%

2020

Worst year
−53.90%

2022

Volatility is the annualized standard deviation of daily returns. As of October 21, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Top Holdings

# Symbol Name Weight
1 TWST Twist Bioscience Corp 10.31%
2 TXG 10x Genomics Inc Ordinary Shares - Class A 10.02%
3 TEM Tempus AI Inc Class A common stock 8.93%
4 CRSP CRISPR Therapeutics AG 5.24%
5 ABSI Absci Corp 5.06%
6 PSNL Personalis Inc 4.88%
7 GH Guardant Health Inc 4.61%
8 NTRA Natera Inc 4.53%
9 ILMN Illumina Inc 4.5%
10 CDNA CareDx Inc 4.34%

Analysis

Data-derived

Fund Overview

ARK Genomic Revolution ETF trades as ARKG and is categorised as Health. The fund holds $2.22B in total net assets. The expense ratio is 0.75%. On a $10,000 position that is $75.00 a year. ARK ETF Trust is the fund family on file. It has been trading since October 31, 2014.

The largest positions on file are Twist Bioscience Corp (TWST), 10x Genomics Inc Ordinary Shares - Class A (TXG), and Tempus AI Inc Class A common stock (TEM). Twist Bioscience Corp alone accounts for 10.31% of the portfolio. The ten largest positions together make up 62.42% of the fund.

Performance Analysis

ARKG last closed at $49.85 on October 21, 2026. The trailing one-year total return is +52.63%. Across 10 years the annualized return works out at +11.78%.

2026 is still running; the total return is +72.07% year to date. The strongest complete calendar year on file is 2020 at +180.40%; the weakest is 2022 at −53.90%. Of the 9 complete calendar years on file, 5 finished higher.

Price & Risk Profile

Annualized volatility over the trailing 10 years is 41.94%. The reported beta is 2.21. The 52-week range on file runs from $24.60 to $58.83. The latest close sits 102.64% above that 52-week low. The volatility figure is calculated from the stored daily closes, the same series the charts on this page use.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Health ETFs

XLV

State Street Health Care Select Sector SPDR ETF

$43.39B

 VHT

Vanguard Health Care Index Fund ETF Shares

$21.81B

 IBB

iShares Biotechnology ETF

$11.20B

 XBI

State Street SPDR S&P Biotech ETF

$10.36B
View all Health ETFs →